These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26838030)

  • 1. Complete loss of STAG2 expression is an indicator of good prognosis in patients with bladder cancer.
    Qiao Y; Zhu X; Li A; Yang S; Zhang J
    Tumour Biol; 2016 Aug; 37(8):10279-86. PubMed ID: 26838030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of aquaporin 3 protein expression constitutes an independent prognostic factor for progression-free survival: an immunohistochemical study on stage pT1 urothelial bladder cancer.
    Otto W; Rubenwolf PC; Burger M; Fritsche HM; Rößler W; May M; Hartmann A; Hofstädter F; Wieland WF; Denzinger S
    BMC Cancer; 2012 Oct; 12():459. PubMed ID: 23043286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer.
    Ruan J; Wei B; Xu Z; Yang S; Zhou Y; Yu M; Liang J; Jin K; Huang X; Lu P; Cheng H
    Med Oncol; 2013 Mar; 30(1):445. PubMed ID: 23307254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancer.
    Taber A; Park Y; Lelo A; Prip F; Xiao J; Berry DL; Chaldekas K; Jensen JB; Philips G; Kim JS; Harris BT; Dyrskjøt L; Waldman T
    Urol Oncol; 2021 Jul; 39(7):438.e1-438.e9. PubMed ID: 33712344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromodomain 4 protein is a predictor of survival for urothelial carcinoma of bladder.
    Yan Y; Yang FQ; Zhang HM; Li J; Li W; Wang GC; Che JP; Zheng JH; Liu M
    Int J Clin Exp Pathol; 2014; 7(7):4231-8. PubMed ID: 25120803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder.
    Liu JY; Li YH; Lin HX; Liao YJ; Mai SJ; Liu ZW; Zhang ZL; Jiang LJ; Zhang JX; Kung HF; Zeng YX; Zhou FJ; Xie D
    BMC Cancer; 2013 Jul; 13():349. PubMed ID: 23870412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival.
    Breyer J; Wirtz RM; Otto W; Erben P; Kriegmair MC; Stoehr R; Eckstein M; Eidt S; Denzinger S; Burger M; Hartmann A;
    Virchows Arch; 2017 Mar; 470(3):267-274. PubMed ID: 28074276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of heme oxygenase-1, S100 calcium-binding protein A4, and syndecan-1 expression in primary non-muscle-invasive bladder cancer.
    Kim JH; Park J
    Hum Pathol; 2014 Sep; 45(9):1830-8. PubMed ID: 24957789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of protocadherin7 (PCDH7) is a potential prognostic biomarker for primary non-muscle invasive bladder cancer.
    Lin YL; Wang YL; Fu XL; Li WP; Wang YH; Ma JG
    Oncotarget; 2016 May; 7(19):28384-92. PubMed ID: 27070091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
    Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
    Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slingshot homolog-1 expression is a poor prognostic factor of pT1 bladder urothelial carcinoma after transurethral resection.
    Luo Q; Liu Y; Zhao H; Guo P; Wang Q; Li W; Li G; Wu B
    World J Urol; 2020 Nov; 38(11):2849-2856. PubMed ID: 31965287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Argonaute 2 is up-regulated in tissues of urothelial carcinoma of bladder.
    Yang FQ; Huang JH; Liu M; Yang FP; Li W; Wang GC; Che JP; Zheng JH
    Int J Clin Exp Pathol; 2014; 7(1):340-7. PubMed ID: 24427355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC).
    Nicklas AP; Kramer MW; Serth J; Hennenlotter J; Hupe MC; Reimer DU; Stenzl A; Merseburger AS; Kuczyk MA; von Klot CJ
    Adv Ther; 2018 Nov; 35(11):2054-2068. PubMed ID: 30232708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
    Bertz S; Otto W; Denzinger S; Wieland WF; Burger M; Stöhr R; Link S; Hofstädter F; Hartmann A
    Eur Urol; 2014 Jan; 65(1):218-26. PubMed ID: 22633802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of nuclear prothymosin-α expression is associated with disease progression in human superficial bladder cancer.
    Tsai YS; Jou YC; Tung CL; Lin CT; Shen CH; Chen SY; Tsai HT; Lai CL; Wu CL; Tzai TS
    Virchows Arch; 2014 Jun; 464(6):717-24. PubMed ID: 24733561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell Cycle Markers in the Evaluation of Bladder Cancer.
    da Silva JNL; Ranzi AD; Carvalho CT; Scheide TV; Strey YTM; Graziottin TM; Bica CG
    Pathol Oncol Res; 2020 Jan; 26(1):175-181. PubMed ID: 29524168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncological Outcomes in Patients Treated with Radical Cystectomy for Bladder Cancer: Comparison Between Open, Laparoscopic, and Robot-Assisted Approaches.
    Kim TH; Sung HH; Jeon HG; Seo SI; Jeon SS; Lee HM; Choi HY; Jeong BC
    J Endourol; 2016 Jul; 30(7):783-91. PubMed ID: 27055782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer.
    Boman K; Segersten U; Ahlgren G; Eberhard J; Uhlén M; Jirström K; Malmström PU
    BMC Urol; 2013 Apr; 13():17. PubMed ID: 23565664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor expression correlates with disease-specific survival in patients with node-negative muscle-invasive bladder cancer.
    Patry G; Hovington H; Larue H; Harel F; Fradet Y; Lacombe L
    Int J Cancer; 2008 Apr; 122(7):1592-7. PubMed ID: 18058798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.
    Luo Y; Zhang X; Mo M; Tan Z; Huang L; Zhou H; Wang C; Wei F; Qiu X; He R; Chen G
    Medicine (Baltimore); 2016 Apr; 95(15):e3337. PubMed ID: 27082587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.